Guanfacine
- Product NDC
- 73141-018
- 11-digit product format
- 731410018
- Labeler code
- 73141
- Product ID
- 73141-018_32c1e44a-6ccf-c3c7-e063-6394a90ad7fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gaunfacine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A2A Integrated Pharmaceuticals
- Application
- ANDA216828
- Marketing category
- ANDA
- Marketing start
- 2025-04-08
- Substance
- GUANFACINE HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Guanfacine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUANFACINE HYDROCHLORIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PML56A160O |
| Rxcui | 197745, 197746 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73141-018-04 | Guanfacine | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73141-018 | GUANFACINE (GAUNFACINE) TABLET [A2A INTEGRATED PHARMACEUTICALS] | 1 | Current NDC, 1 package rows | 20250416_00c3b4d2-fc4d-4e68-9157-eb29d927deaf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 73141-018-04 | 73141001804 | 100 TABLET in 1 BOTTLE (73141-018-04) | 100 tablet | 2025-04-08 | No | No | Current |